Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 16/20 | 0.61 |
| ▸ | MAPK11 | Q15759 | 7/20 | 0.61 |
| ▸ | MAPK13 | O15264 | 6/20 | 0.61 |
| ▸ | MAPK9 | P45984 | 6/20 | 0.61 |
| ▸ | MAPK12 | P53778 | 6/20 | 0.61 |
| ▸ | RAF1 | P04049 | 4/20 | 0.61 |
| ▸ | CSNK1A1 | P48729 | 4/20 | 0.59 |
| ▸ | CSNK1D | P48730 | 4/20 | 0.59 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.59 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.59 |
| ▸ | PRKCA | P17252 | 2/20 | 0.59 |
| ▸ | MINK1 | Q8N4C8 | 2/20 | 0.59 |
| ▸ | MAP4K5 | Q9Y4K4 | 2/20 | 0.59 |
| ▸ | HSPB1 | P04792 | 1/20 | 0.59 |
| ▸ | PRKCB | P05771 | 1/20 | 0.59 |
| ▸ | PRKACA | P17612 | 1/20 | 0.59 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.49 |
| ▸ | BRDT | Q58F21 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | EGFR | P00533 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8113515 | 0.94 | CSNK1D (0.56) | MAPK14MAPK11MAPK13MAPK9MAPK12 | |
| SCHEMBL8108392 | 0.92 | MAPK14 (0.58) | MAPK14MAPK11MAPK13MAPK9MAPK12 | |
| SCHEMBL8108276 | 0.92 | MAPK14 (0.56) | MAPK14MAPK11MAPK13MAPK9MAPK12 | |
| SCHEMBL8108398 | 0.91 | MAPK14 (0.60) | MAPK14MAPK11MAPK13MAPK9MAPK12 | |
| SCHEMBL8099919 | 0.91 | MAPK14 (0.60) | MAPK14MAPK11MAPK13MAPK9MAPK12 | |
| SCHEMBL4585317 | 0.90 | MAPK14 (0.63) | MAPK14MAPK11MAPK13MAPK9MAPK12 | |
| SCHEMBL4583070 | 0.90 | MAPK14 (0.60) | MAPK14MAPK11MAPK13MAPK9MAPK12 | |
| SCHEMBL4584282 | 0.90 | MAPK14 (0.63) | MAPK14MAPK11MAPK13MAPK9MAPK12 | |
| SCHEMBL4584295 | 0.89 | MAPK14 (0.61) | MAPK14MAPK11MAPK13MAPK9MAPK12 | |
| SCHEMBL4584672 | 0.89 | MAPK14 (0.60) | MAPK14MAPK11MAPK13MAPK9MAPK12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1337255-A4 | USE OF P38 INHIBITORS FOR THE TREATMENT OF INFLAMMATION-ENHANCED COUGH | SMITHKLINE BEECHAM CORP (US) | 2006-01-25 | — | — | EP | claimed |
| EP-1223924-A4 | USE OF CSAIDS IN RHINOVIRUS INFECTION | SMITHKLINE BEECHAM CORP (US) | 2004-07-14 | — | — | EP | claimed |
| EP-1337255-A2 | USE OF P38 INHIBITORS FOR THE TREATMENT OF INFLAMMATION-ENHANCED COUGH | SmithKline Beecham Corporation (US) | 2003-08-27 | — | — | EP | claimed |
| EP-1337250-A2 | USE OF P38 INHIBITORS FOR THE TREATMENT OF SMOKE INHALATION | SmithKline Beecham Corporation (US) | 2003-08-27 | — | — | EP | claimed |
| JP-2003516314-A | — | — | 2003-05-13 | — | — | JP | claimed |
| WO-2002060869-A2 | USE OF P38 INHIBITORS FOR THE TREATMENT OF INFLAMMATION-ENHANCED COUGH | SMITHKLINE BEECHAM CORPORATION (US) | 2002-08-08 | — | — | WO | claimed |
| EP-1223924-A2 | USE OF CSAIDS IN RHINOVIRUS INFECTION | SmithKline Beecham Corporation (US) | 2002-07-24 | — | — | EP | claimed |
| WO-2002032862-A2 | USE OF P38 INHIBITORS FOR THE TREATMENT OF SMOKE INHALATION | SMITHKLINE BEECHAM CORPORATION (US) | 2002-04-25 | — | — | WO | claimed |
| WO-2001019322-A2 | USE OF CSAIDS IN RHINOVIRUS INFECTION | SMITHKLINE BEECHAM CORPORATION (US) | 2001-03-22 | — | — | WO | claimed |
| EP-1539121-A4 | METHODS OF PROMOTING OSTEOGENESIS | SCIOS INC (US) | 2008-08-13 | — | — | EP | disclosed |
| EP-1545535-A4 | TREATMENT OF PAIN BY INHIBITION OF P38 MAP KINASE | SCIOS INC (US) | 2008-06-04 | — | — | EP | disclosed |
| EP-1583535-A4 | METHODS FOR TREATING DIABETES | SCIOS INC (US) | 2008-03-19 | — | — | EP | disclosed |
| EP-1583535-A2 | METHODS FOR TREATING DIABETES | SCIOS INC. (US) | 2005-10-12 | — | — | EP | disclosed |
| EP-1545535-A2 | TREATMENT OF PAIN BY INHIBITION OF P38 MAP KINASE | SCIOS INC. (US) | 2005-06-29 | — | — | EP | disclosed |
| WO-2004021988-A2 | TREATMENT OF PAIN BY INHIBITION OF P38 MAP KINASE | SCIOS INC. (US) | 2004-03-18 | — | — | WO | disclosed |
| WO-2004019873-A2 | METHODS OF PROMOTING OSTEOGENESIS | SCIOS INC. (US) | 2004-03-11 | — | — | WO | disclosed |
| EP-1337250-A2 | USE OF P38 INHIBITORS FOR THE TREATMENT OF SMOKE INHALATION | SmithKline Beecham Corporation (US) | 2003-08-27 | — | — | EP | disclosed |
| EP-1223924-A2 | USE OF CSAIDS IN RHINOVIRUS INFECTION | SmithKline Beecham Corporation (US) | 2002-07-24 | — | — | EP | disclosed |
| WO-2002032862-A2 | USE OF P38 INHIBITORS FOR THE TREATMENT OF SMOKE INHALATION | SMITHKLINE BEECHAM CORPORATION (US) | 2002-04-25 | — | — | WO | disclosed |
| WO-2001019322-A2 | USE OF CSAIDS IN RHINOVIRUS INFECTION | SMITHKLINE BEECHAM CORPORATION (US) | 2001-03-22 | — | — | WO | disclosed |